FORMULE 37805 DIN 00241571
Health Canada record
| Active ingredient(s) | CALCIUM GLYCEROPHOSPHATE 22 MG; BETAINE HYDROCHLORIDE 27 MG; POTASSIUM BICARBONATE 18 MG; CHOLINE BITARTRATE 4 MG; RIBONUCLEIC ACID 3 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1951 |
| Current status date | 09-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Therapeutic Products Inc — licence 3-002321, not currently licensed, last inspection rating C (2017-02-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CALCIUM GLYCEROPHOSPHATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00532762 | CALCIUM INJ | KRIPPS PHARMACY LTD. | Liquid | CALCIUM GLYCEROPHOSPHATE 10 MG; CALCIUM LEVULINATE 15 MG | Dormant |
| 00052426 | CALPHOSAN SUSPENSION | AUSTIN, DIVISION OF VÉTOQUINOL N.-A. INC. | Suspension | CALCIUM GLYCEROPHOSPHATE 50 MG; CALCIUM LACTATE 50 MG | Cancelled Post Market |
| 00166219 | TRIOGENE FOR | PRODUITS FRANCAIS LABS INC. | Powder | CALCIUM GLYCEROPHOSPHATE 549.25 MG; GENTIANA LUTEA 53.3 MG; KOLA 161.2 MG; QUININE 71.37 MG; IRON 209.82 MG | Cancelled Post Market |
International API supply for CALCIUM GLYCEROPHOSPHATE
0 valid EDQM Certificates of Suitability from 0 holders.
Request a quote for FORMULE 37805